BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
|
Back to Search Results |
|
Model Number G140 |
Device Problem
High impedance (1291)
|
Patient Problem
Device Overstimulation of Tissue (1991)
|
Event Date 10/06/2022 |
Event Type
malfunction
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited pacing impedance values of greater than 3000 ohms on all tested vector configurations.Patient experienced stimulation during lv lead vector testing.It was noted that patient had an echocardiogram.Technical services (ts) analyzed presenting electrogram (egm) and found that there was no loss of capture.Subsequently, ts provided troubleshooting including testing impedances measurements on other vectors.Lead replacement was recommended.Patient is scheduled for an echocardiogram.No additional adverse patient effects were reported.Currently, this device remains in service.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited pacing impedance values of greater than 3000 ohms on all tested vector configurations.Patient experienced stimulation during lv lead vector testing.It was noted that patient had an echocardiogram.Technical services (ts) analyzed presenting electrogram (egm) and found that there was no loss of capture.Subsequently, ts provided troubleshooting including testing impedances measurements on other vectors.Lead replacement was recommended.Patient is scheduled for an echocardiogram.No additional adverse patient effects were reported.Currently, this device remains in service.Later, this product was received by boston scientific and full investigation was conducted.
|
|
Manufacturer Narrative
|
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.Dimensional analysis of the header was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
|
|
Search Alerts/Recalls
|
|
|